Search Within

Alexander Edward Drilon

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (76)
  2. Meeting Abstract (75)
  3. Research Letter (2)
  4. Book Section (1)
  5. Editorial (1)
  6. Guidelines (1)
Groups
  1. Department of Medicine (156)
  2. GSK Faculty (156)
  3. Human Oncology and Pathogenesis Program (156)
  4. Solid Tumor Oncology Division (156)
  5. Thoracic Oncology (156)
  6. Department of Pathology and Laboratory Medicine (150)

More Groups

People
  1. Marc Ladanyi (121)
  2. Maria Arcila (64)
  3. Mark Kris (54)
  4. Michael Berger (51)
  5. Charles Rudin (45)
  6. Gregory Riely (44)

More People

Years
  1. 2025 (2)
  2. 2024 (12)
  3. 2023 (9)
  4. 2022 (17)
  5. 2021 (14)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (33)
  2. Journal of Thoracic Oncology (19)
  3. Clinical Cancer Research (17)
  4. Cancer Research (9)
  5. JCO Precision Oncology (9)
  6. Cancer Discovery (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (43)
  2. American Association for Cancer Research (36)
  3. Elsevier Inc. (22)
  4. Nature Publishing Group (14)
  5. Oxford University Press (9)
  6. Elsevier Science, Inc. (8)

More Publishers

Results (156)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic ancestry-based differences in biomarker-based eligibility for precision oncology therapies
    Journal Article

    Arora, K.; Suehnholz, S. P.; Zhang, H.; Ostrovnaya, I.; Kundra, R.; Nandakumar, S.; Nissan, M. H.; Brannon, A. R.; Bandlamudi, C.; Ladanyi, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Next-generation sequencing for HLA genotype screening and matching to HLA-restricted therapies
    Research Letter

    Gormally, M. V.; Chen, M. F.; Noronha, A. M.; Panageas, K.; Reynolds, M.; Kohlasch, K.; Novak, B.; Kee-Velez, T.; Clarke, N.; Eubank, M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Comprehensive pan-cancer analysis of oncogenic MET rearrangements with a focus on targetability in NSCLC
    Meeting Abstract

    Vojnic, M.; Febres-Aldana, C. A.; Odintsov, I.; Zhang, T.; Beach, C. Z.; Lu, D.; Mattar, M. S.; Gazzo, A.; Gili, L.; Harshan, M.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • OncoKB: Automated somatic variant classification for rapid clinical decision making
    Meeting Abstract

    Suehnholz, S.; Nissan, M.; Zhang, H.; Kundra, R.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Cavender, K.; Preiser, B.; Konecny, J.; more...
    Journal of Molecular Diagnostics (2024)

    Fulltext@MSK | Save
  • Intratumoral escherichia is associated with improved survival to single-agent immune checkpoint inhibition in patients with advanced non–small-cell lung cancer
    Journal Article

    Elkrief, A.; Montesion, M.; Sivakumar, S.; Hale, C.; Bowman, A. S.; Begüm Bektaş, A.; Bradic, M.; Kang, W.; Chan, E.; Gogia, P.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Tumor-agnostic genomic and clinical analysis of BRAF fusions identifies actionable targets
    Journal Article

    Chen, M. F.; Yang, S. R.; Tao, J. J.; Desilets, A.; Diamond, E. L.; Wilhelm, C.; Rosen, E.; Gong, Y.; Mullaney, K.; Torrisi, J.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Association of ERBB2 extrachromosomal DNA (ecDNA) with first-line HER2-targeted treatment outcomes in advanced esophagogastric adenocarcinoma (EGC)
    Meeting Abstract

    Tsai, C.; Suman, S.; Chu, C.; Chou, J. F.; Krein, P. M.; Capanu, M.; Ilson, D. H.; Ku, G. Y.; Janjigian, Y. Y.; Drilon, A. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Germline and somatic MUTYH mutations: Clinicopathologic and mutational analysis in a pan-cancer cohort
    Meeting Abstract

    Desilets, A.; Repetto, M.; Kemel, Y.; Khurram, A.; Mandelker, D.; Bandlamudi, C.; Novak, B.; Velilla, C.; Selenica, P.; Richards, A. L.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Tracking the FDA precision oncology drug approval landscape in OncoKB
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Zhang, H.; Nissan, M. H.; Lu, C.; Dhaneshwar, A.; Fernandez, N.; Nandakumar, S.; Arcila, M. E.; Ladanyi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save